Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_09653 | 51 | 1.06 | Mlig455_044944 | Neo: - Age: - |
SLC17A6 | Mlig455_044944 {REF} {Length: 2769} {Pfam: Major Facilitator Superfamily [PF07690.18, score=118.9]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [Score=260, Expect=4e-79]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [Score=248, Expect=1e-74]} {Mouse: ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [Score=259, Expect=8e-79]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [Score=249, Expect=3e-75]; ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [Score=248, Expect=2e-74]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=223, Expect=1e-64]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [Score=203, Expect=2e-58]} {Smed: dd_Smed_v6_21295_0_1, dd_Smed_v6_21295_0_1, [RH, Score=616, Expect=0.0]} {RNA1310_79790} {RNA815_45443} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -5.66 | 1.37 | 1.00000 | 1.00000 | |
RegionR2 | 3.844 | 1.37 | 0.01166 | 0.11088 | |
RegionR3 | 1.263 | 1.37 | 0.40054 | 0.92881 | |
RegionR4 | 1.088 | 1.37 | 0.35483 | 0.67710 | |
RegionR5 | -0.534 | 1.37 | 0.90997 | 1.00000 | |
RegionR6 | 1.304 | 1.37 | 0.38598 | 0.96301 | |
RegionR7 | 2.587 | 1.37 | 0.08973 | 0.57425 | |
RegionR8 | -3.892 | 1.37 | 1.00000 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 0.621 | 1.37 | 0.99998 | 1.00000 | |
RegenerationR2 | 0.473 | 1.37 | 0.52256 | 0.88024 | |
RegenerationR3 | 0.73 | 1.37 | 0.49805 | 0.85685 | |
RegenerationR4 | -2.253 | 1.37 | 0.05677 | 0.38217 | |
RegenerationR5 | 0.498 | 1.37 | 0.63310 | 0.92349 | |
RegenerationR6 | -3.495 | 1.37 | 0.04684 | 0.27054 | |
RegenerationBL | 0.79 | 1.37 | 0.61061 | 0.95568 | |
RegenerationTP | 1.921 | 1.37 | 0.39298 | 0.82427 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_09653 | 51 | 1.06 | Mlig455_044944 | Neo: - Age: - |
SLC17A6 | 5 | - | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_044944 {REF} {Length: 2769} {Pfam: Major Facilitator Superfamily [PF07690.18, score=118.9]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [Score=260, Expect=4e-79]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [Score=248, Expect=1e-74]} {Mouse: ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [Score=259, Expect=8e-79]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [Score=249, Expect=3e-75]; ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [Score=248, Expect=2e-74]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=223, Expect=1e-64]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [Score=203, Expect=2e-58]} {Smed: dd_Smed_v6_21295_0_1, dd_Smed_v6_21295_0_1, [RH, Score=616, Expect=0.0]} {RNA1310_79790} {RNA815_45443} |
2. | MligTC455_50464 | 64 | 1.34 | Mlig455_007906, Mlig455_008010 | Neo: - Age: - |
3.561 | - | 0.931 | - | 0.790 | 0.874 | 0.966 | Mlig455_007906 {REF} {Length: 3294} {RNA1509_46103} {RNA1310_23886.1} {RNA815_8813.1} Mlig455_008010 {REF} {Length: 1139} {RNA1509_46103} {RNA1310_23886.1} {RNA815_8813.1} |
|
3. | MligTC455_35258 | 2779 | 57.89 | Mlig455_040964 | Neo: - Age: Up-Down-Down Region-specific R2: 2.469 Region-enriched R2: 1.501/0.00133 |
3.536 | - | 0.816 | - | 0.811 | 0.936 | 0.973 | Mlig455_040964 {REF} {Length: 8259} {Smed: dd_Smed_v6_8425_0_1, dd_Smed_v6_8425_0_1, [Score=543, Expect=9e-160]} {RNA1509_16633, RNA1509_52679} {RNA1310_236.2, RNA1509_16633} {RNA1509_16633, RNA815_77.1} | |
4. | MligTC455_39956 | 118 | 2.47 | Mlig455_038145 | Neo: - Age: - Region-enriched R2: 5.450/0.00015 |
ADGB | 3.52 | - | 0.846 | - | 0.847 | 0.876 | 0.951 | Mlig455_038145 {REF} {Length: 7557} {tRNA: Ile(TAT),pseudo, score=35.9} {Pfam: Calpain family cysteine protease [PF00648.23, score=31.4]} {Human: ENSG00000118492, ADGB, androglobin, [Score=431, Expect=4e-124]} {Mouse: ENSMUSG00000050994, Adgb, androglobin, [Score=255, Expect=7e-68]} {Celegans: WBGene00000543, clp-2, CaLPain family, [Score=73.2, Expect=1e-12]} {Smed: dd_Smed_v6_10677_0_1, dd_Smed_v6_10677_0_1, [Score=248, Expect=2e-66]} {RNA1509_15950, RNA1509_36374, RNA1509_49600} {RNA1310_4821, RNA1509_15950, RNA1509_36374, RNA1509_49600} {RNA1509_15950, RNA1509_36374, RNA1509_49600, RNA815_11351} |
5. | MligTC455_35259 | 2265 | 47.19 | Mlig455_040978 | Neo: - Age: Up-Down-Down Region-specific R2: 2.606 Region-enriched R2: 1.588/0.00387 |
ADGRL2 | 3.473 | - | 0.821 | - | 0.799 | 0.874 | 0.979 | Mlig455_040978 {REF} {Length: 10808} {TRANSSPLICED} {Pfam: PDZ domain [PF00595.26, score=86.9]; 7 transmembrane receptor (Secretin family) [PF00002.26, score=76.2]; PDZ domain [PF17820.3, score=67.3]; GPCR proteolysis site, GPS, motif [PF01825.23, score=52.3]; PDZ domain [PF13180.8, score=36.4]; ZU5 domain [PF00791.22, score=30.8]; Guanylate kinase [PF00625.23, score=22.4]} {Human: ENSG00000117114, ADGRL2, adhesion G protein-coupled receptor L2, [RH, Score=174, Expect=1e-42]} {Mouse: ENSMUSG00000034917, Tjp3, tight junction protein 3, [RH, Score=172, Expect=9e-43]} {Dmel: FBgn0262614, pyd, polychaetoid, [RH, Score=232, Expect=8e-61]} {Celegans: WBGene00013683, zoo-1, ZO-1 (Zonula Occludens tight junctional protein) Ortholog, [Score=174, Expect=4e-43]} {Smed: dd_Smed_v6_8425_0_1, dd_Smed_v6_8425_0_1, [RH, Score=833, Expect=0.0]} {RNA1509_17602, RNA1509_52679, RNA1509_58629} {RNA1310_236.2, RNA1509_17602, RNA1509_58629} {RNA1509_17602, RNA1509_58629, RNA815_77.1} |
6. | MligTC455_19278 | 4335 | 90.31 | Mlig455_057304, Mlig455_070944 | Neo: - Age: logFC(26M/2M)=0.686 Region-specific R2: 5.590 Region-enriched R2: 5.465/0.00000 |
CHRNA10 | 3.472 | - | 0.763 | - | 0.757 | 0.964 | 0.988 | Mlig455_057304 {REF} {Length: 1001} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=71.6]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=77.0, Expect=2e-16]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=75.9, Expect=4e-16]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=75.5, Expect=6e-16]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=73.9, Expect=2e-15]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=93.6, Expect=2e-22]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=100, Expect=5e-25]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=82.8, Expect=8e-19]} {RNA1509_23115} {RNA1310_34970} {RNA815_15305.1} Mlig455_070944 {REF} {Length: 1060} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=88.2]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=95.9, Expect=6e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=96.3, Expect=3e-22]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=94.7, Expect=1e-21]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=112, Expect=7e-28]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=118, Expect=4e-30]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=98.6, Expect=2e-23]} {RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1310_34970, RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1509_23115, RNA1509_43907, RNA1509_9432, RNA815_15305.1} |
7. | MligTC455_48766 | 985 | 20.53 | Mlig455_020052, Mlig455_022298 | Neo: - Age: logFC(26M/2M)=-0.287 |
ODF3 | 3.462 | - | 0.834 | - | 0.795 | 0.872 | 0.961 | Mlig455_020052 {REF} {Length: 1742} {TRANSSPLICED} {Pfam: Sperm-tail PG-rich repeat [PF07004.14, score=82.0]} {Human: ENSG00000177947, ODF3, outer dense fiber of sperm tails 3, [RH, Score=188, Expect=6e-59]} {Mouse: ENSMUSG00000025482, Odf3, outer dense fiber of sperm tails 3, [RH, Score=187, Expect=1e-58]} {Dmel: FBgn0032010, CG8086, [RH, Score=119, Expect=2e-32]} {Smed: dd_Smed_v6_2658_0_1, dd_Smed_v6_2658_0_1, [Score=304, Expect=4e-105]} {RNA1509_28289, RNA1509_56680} {RNA1310_15149, RNA1509_56680} {RNA1509_56680, RNA815_9422} Mlig455_022298 {REF} {Length: 2031} {TRANSSPLICED} {Pfam: Sperm-tail PG-rich repeat [PF07004.14, score=82.0]} {Human: ENSG00000177947, ODF3, outer dense fiber of sperm tails 3, [RH, Score=188, Expect=6e-59]} {Mouse: ENSMUSG00000025482, Odf3, outer dense fiber of sperm tails 3, [RH, Score=187, Expect=1e-58]} {Dmel: FBgn0032010, CG8086, [RH, Score=119, Expect=2e-32]} {Smed: dd_Smed_v6_2658_0_1, dd_Smed_v6_2658_0_1, [Score=304, Expect=4e-105]} {RNA1509_28289, RNA1509_54276} {RNA1310_15149, RNA1509_28289, RNA1509_54276} {RNA1509_28289, RNA1509_54276, RNA815_9422} |
8. | MligTC455_19276 | 1694 | 35.28 | Mlig455_057303 | Neo: - Age: Down-Down-Up Region-specific R2: 5.711 Region-enriched R2: 6.117/0.00000 |
3.461 | - | 0.765 | - | 0.743 | 0.965 | 0.988 | Mlig455_057303 {REF} {Length: 1196} {Pfam: TATA-binding related factor (TRF) of subunit 20 of Mediator complex [PF08612.13, score=80.6]} {Smed: dd_Smed_v6_9879_0_1, dd_Smed_v6_9879_0_1, [RH, Score=73.9, Expect=1e-15]} {RNA1509_58478} {RNA1310_35292} {RNA815_20171} | |
9. | MligTC455_37720 | 156 | 3.25 | Mlig455_027725, Mlig455_027921, Mlig455_027931 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.630/0.03113 |
TRPV6 | 3.443 | - | 0.900 | - | 0.712 | 0.859 | 0.972 | Mlig455_027725 {REF} {Length: 5690} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=53.7]; Ion transport protein [PF00520.33, score=39.6]; Ankyrin repeat [PF13606.8, score=33.0]; Ankyrin repeats (many copies) [PF13857.8, score=30.8]; Ankyrin repeat [PF00023.32, score=29.7]; Polycystin cation channel [PF08016.14, score=27.5]; Ankyrin repeats (many copies) [PF13637.8, score=21.3]} {Human: ENSG00000165125, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=207, Expect=4e-55]; ENSG00000276971, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=206, Expect=4e-55]} {Mouse: ENSMUSG00000029868, Trpv6, transient receptor potential cation channel, subfamily V, member 6, [Score=206, Expect=1e-54]} {Dmel: FBgn0086693, iav, inactive, [RH, Score=568, Expect=0.0]} {Celegans: WBGene00003889, osm-9, Olfactory channel, [RH, Score=489, Expect=8e-156]} {Smed: dd_Smed_v6_28914_0_1, dd_Smed_v6_28914_0_1, [Score=492, Expect=6e-158]} {RNA1509_36869} {RNA1310_5278, RNA1509_36869} {RNA1509_36869, RNA815_5723} Mlig455_027921 {REF} {Length: 8298} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=53.7]; Ion transport protein [PF00520.33, score=39.2]; Ankyrin repeat [PF13606.8, score=33.0]; Ankyrin repeats (many copies) [PF13857.8, score=30.8]; Ankyrin repeat [PF00023.32, score=29.8]; Polycystin cation channel [PF08016.14, score=27.1]; Ankyrin repeats (many copies) [PF13637.8, score=21.3]} {Human: ENSG00000165125, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=207, Expect=4e-55]; ENSG00000276971, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=206, Expect=5e-55]} {Mouse: ENSMUSG00000029868, Trpv6, transient receptor potential cation channel, subfamily V, member 6, [Score=206, Expect=9e-55]} {Dmel: FBgn0086693, iav, inactive, [RH, Score=566, Expect=0.0]} {Celegans: WBGene00003889, osm-9, Olfactory channel, [RH, Score=488, Expect=1e-155]} {Smed: dd_Smed_v6_28914_0_1, dd_Smed_v6_28914_0_1, [Score=491, Expect=1e-157]} {RNA1509_36869} {RNA1310_5278} {RNA815_5723} Mlig455_027931 {REF} {Length: 6147} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=53.7]; Ion transport protein [PF00520.33, score=40.0]; Ankyrin repeat [PF13606.8, score=34.3]; Ankyrin repeats (many copies) [PF13857.8, score=31.5]; Ankyrin repeat [PF00023.32, score=30.2]; Polycystin cation channel [PF08016.14, score=27.8]; Ankyrin repeats (many copies) [PF13637.8, score=21.7]} {Human: ENSG00000276971, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=208, Expect=7e-56]; ENSG00000165125, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=207, Expect=1e-55]} {Mouse: ENSMUSG00000029868, Trpv6, transient receptor potential cation channel, subfamily V, member 6, [Score=206, Expect=3e-55]} {Dmel: FBgn0086693, iav, inactive, [RH, Score=567, Expect=0.0]} {Celegans: WBGene00003889, osm-9, Olfactory channel, [RH, Score=488, Expect=5e-157]} {Smed: dd_Smed_v6_28914_0_1, dd_Smed_v6_28914_0_1, [Score=490, Expect=4e-159]} {RNA1509_36869} {RNA1310_5278} {RNA815_5723} |
10. | MligTC455_50532 | 259 | 5.4 | Mlig455_019987 | Neo: - Age: Down-Up-Down |
NEFH | 3.415 | - | 0.840 | - | 0.723 | 0.897 | 0.955 | Mlig455_019987 {REF} {Length: 4055} {Human: ENSG00000100285, NEFH, neurofilament heavy, [Score=65.5, Expect=3e-10]} {RNA1509_41200, RNA1509_57173} {RNA1310_3614.2, RNA1509_41200, RNA1509_57173} {RNA1509_41200, RNA1509_57173, RNA815_5328} |
11. | MligTC455_33854 | 41 | 0.85 | Mlig455_031601 | Neo: - Age: - Region-enriched R2: 5.730/0.00808 |
3.412 | - | - | 0.765 | 0.722 | 0.983 | 0.942 | Mlig455_031601 {REF} {Length: 1072} {RNA1310_42312} {RNA815_56269} | |
12. | MligTC455_53843 | 1448 | 30.17 | Mlig455_048664 | Neo: - Age: logFC(26M/2M)=0.488 |
3.404 | - | - | 0.719 | 0.837 | 0.891 | 0.957 | Mlig455_048664 {REF} {Length: 1660} {RNA1509_15580} {RNA1310_24090, RNA1509_15580} {RNA1509_15580, RNA815_10676.2} | |
13. | MligTC455_52120 | 179 | 3.73 | Mlig455_024423, Mlig455_024577 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.068/0.01755 |
POU4F3 | 3.399 | - | 0.722 | - | 0.820 | 0.894 | 0.963 | Mlig455_024423 {REF} {Length: 1288} {TRANSSPLICED} {Pfam: Pou domain - N-terminal to homeobox domain [PF00157.19, score=104.8]; Homeodomain [PF00046.31, score=60.9]} {Human: ENSG00000091010, POU4F3, POU class 4 homeobox 3, [Score=212, Expect=1e-65]; ENSG00000152192, POU4F1, POU class 4 homeobox 1, [Score=211, Expect=2e-64]} {Mouse: ENSMUSG00000024497, Pou4f3, POU domain, class 4, transcription factor 3, [Score=212, Expect=7e-66]; ENSMUSG00000048349, Pou4f1, POU domain, class 4, transcription factor 1, [Score=211, Expect=2e-64]} {Dmel: FBgn0000028, acj6, abnormal chemosensory jump 6, [Score=209, Expect=2e-64]} {Celegans: WBGene00006818, unc-86, Transcription factor unc-86, [Score=188, Expect=4e-57]} {Smed: dd_Smed_v6_30562_0_1, dd_Smed_v6_30562_0_1, [Score=208, Expect=2e-64]} {RNA1509_57422} {RNA1310_23131} {RNA815_34447} Mlig455_024577 {REF} {Length: 1325} {TRANSSPLICED} {Pfam: Pou domain - N-terminal to homeobox domain [PF00157.19, score=104.8]; Homeodomain [PF00046.31, score=60.9]} {Human: ENSG00000091010, POU4F3, POU class 4 homeobox 3, [Score=212, Expect=1e-65]; ENSG00000152192, POU4F1, POU class 4 homeobox 1, [Score=211, Expect=2e-64]} {Mouse: ENSMUSG00000024497, Pou4f3, POU domain, class 4, transcription factor 3, [Score=212, Expect=7e-66]; ENSMUSG00000048349, Pou4f1, POU domain, class 4, transcription factor 1, [Score=211, Expect=2e-64]} {Dmel: FBgn0000028, acj6, abnormal chemosensory jump 6, [Score=209, Expect=2e-64]} {Celegans: WBGene00006818, unc-86, Transcription factor unc-86, [Score=188, Expect=4e-57]} {Smed: dd_Smed_v6_30562_0_1, dd_Smed_v6_30562_0_1, [Score=208, Expect=2e-64]} {RNA1509_57422} {RNA1310_23131} {RNA815_34447} |
14. | MligTC455_49417 | 47 | 0.97 | Mlig455_018820 | Neo: - Age: - |
3.396 | - | 0.809 | - | 0.905 | 0.715 | 0.967 | Mlig455_018820 {REF} {Length: 1221} {RNA1509_32397} {RNA1310_33051} {RNA815_37385} | |
15. | MligTC455_40714 | 93 | 1.94 | Mlig455_008848 | Neo: - Age: - Region-enriched R2: 5.100/0.02617 |
3.372 | - | 0.852 | - | 0.774 | 0.768 | 0.978 | Mlig455_008848 {REF} {Length: 2258} {RNA1310_21537} {RNA815_13165} | |
16. | MligTC455_51537 | 225 | 4.69 | Mlig455_064569 | Neo: - Age: - |
3.364 | - | 0.741 | - | 0.756 | 0.956 | 0.911 | Mlig455_064569 {REF} {Length: 2141} {RNA1310_34295.1} {RNA815_22630} | |
17. | MligTC455_13099 | 93 | 1.93 | Mlig455_057504 | Neo: - Age: - |
3.336 | - | 0.722 | - | 0.856 | 0.802 | 0.956 | Mlig455_057504 {REF} {Length: 2002} {RNA1310_15168} {RNA815_31864} | |
18. | MligTC455_47080 | 362 | 7.54 | Mlig455_037356 | Neo: - Age: - Region-enriched R2: 2.691/0.00566 |
SSUH2 | 3.307 | - | 0.704 | - | 0.761 | 0.870 | 0.972 | Mlig455_037356 {REF} {Length: 1984} {Pfam: DnaJ central domain [PF00684.21, score=20.9]} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=189, Expect=3e-56]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=156, Expect=5e-44]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=90.9, Expect=7e-20]} {RNA1509_29510} {RNA1310_15488, RNA1509_29510} {RNA1509_29510, RNA815_5650} |
19. | MligTC455_47393 | 241 | 5.03 | Mlig455_008718, Mlig455_063579 | Neo: - Age: Down-Up-Down Region-enriched R2: 3.683/0.00849 |
CALM2 | 3.242 | - | 0.740 | - | 0.720 | 0.791 | 0.991 | Mlig455_008718 {REF} {Length: 1727} {Pfam: EF hand [PF00036.34, score=99.3]; EF-hand domain pair [PF13499.8, score=95.1]; EF-hand domain [PF13405.8, score=86.1]; EF-hand domain pair [PF13833.8, score=76.8]; EF hand [PF13202.8, score=75.3]; EF-hand domain [PF14658.8, score=46.0]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=27.9]; EF-hand domain [PF08976.13, score=23.4]; Uncharacterised protein family (UPF0154) [PF03672.15, score=18.7]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=108, Expect=4e-30]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=4e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=4e-30]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-30]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=108, Expect=2e-30]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=1e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-30]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-30]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=114, Expect=8e-33]} {RNA1310_33847.1} {RNA815_17211} Mlig455_063579 {REF} {Length: 2562} {Pfam: EF hand [PF00036.34, score=95.8]; EF-hand domain pair [PF13499.8, score=92.8]; EF-hand domain [PF13405.8, score=82.9]; EF-hand domain pair [PF13833.8, score=74.4]; EF hand [PF13202.8, score=72.2]; EF-hand domain [PF14658.8, score=43.8]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=25.6]; EF-hand domain [PF08976.13, score=21.4]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=111, Expect=7e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=3e-29]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=3e-29]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=111, Expect=7e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-29]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-29]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=9e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-29]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-29]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=111, Expect=9e-31]} {RNA1310_12431.1} {RNA815_17211} |
20. | MligTC455_14830 | 177 | 3.68 | Mlig455_066372 | Neo: - Age: - |
SSUH2 | 3.241 | - | 0.736 | - | 0.756 | 0.783 | 0.966 | Mlig455_066372 {REF} {Length: 1569} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=184, Expect=2e-53]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=148, Expect=1e-40]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=119, Expect=2e-29]} {RNA1509_46058} {RNA1310_5028.1, RNA1509_46058} {RNA1509_46058, RNA815_5650} |
21. | MligTC455_41130 | 1186 | 24.72 | Mlig455_000166, Mlig455_000179, Mlig455_067712 | Neo: - Age: Down-Up-Down Region-specific R2: 5.626 Region-enriched R2: 4.906/0.00009 Regeneration-downregulated R3: -5.200 Regeneration-depleted R3: -5.200 |
3.23 | - | 0.727 | - | 0.763 | 0.775 | 0.965 | Mlig455_000166 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} Mlig455_000179 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} Mlig455_067712 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} |
|
22. | MligTC455_14831 | 280 | 5.83 | Mlig455_067864 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.261/0.00352 |
SSUH2 | 3.179 | - | 0.736 | - | 0.734 | 0.742 | 0.967 | Mlig455_067864 {REF} {Length: 1575} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=184, Expect=6e-54]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=148, Expect=7e-41]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=118, Expect=1e-29]} {RNA1509_46058} {RNA1310_5028.1} {RNA815_5650} |
23. | MligTC455_21755 | 70 | 1.47 | Mlig455_021213 | Neo: - Age: - |
3.174 | - | 0.785 | 0.719 | - | 0.703 | 0.967 | Mlig455_021213 {REF} {Length: 4215} {Pfam: F5/8 type C domain [PF00754.27, score=55.5]} {RNA1509_2515} {RNA1310_33166} {RNA815_14716} | |
24. | MligTC455_53240 | 1601 | 33.35 | Mlig455_025555 | Neo: - Age: - Region-specific R2: 4.178 Region-enriched R2: 2.883/0.00000 |
3.162 | - | 0.722 | - | 0.767 | 0.722 | 0.951 | Mlig455_025555 {REF} {Length: 2163} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=28.0]} {Dmel: FBgn0051221, CG31221, [RH, Score=69.7, Expect=2e-14]} {Celegans: WBGene00010290, F58H1.7, [Score=64.7, Expect=4e-13]} {Smed: dd_Smed_v6_2598_0_1, dd_Smed_v6_2598_0_1, [RH, Score=168, Expect=3e-53]} {RNA1509_58542} {RNA1310_40950, RNA1509_58542} {RNA1509_58542, RNA815_19778.1} | |
25. | MligTC455_13130 | 40 | 0.83 | Mlig455_032511, Mlig455_068691 | Neo: - Age: - |
WSCD2 | 3.149 | - | 0.734 | - | 0.705 | 0.760 | 0.950 | Mlig455_032511 {REF} {Length: 927} {Pfam: WSC domain [PF01822.21, score=40.9]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=50.4, Expect=6e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=50.4, Expect=4e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.1, Expect=2e-10]} {RNA1310_39527} {RNA815_19067} Mlig455_068691 {REF} {Length: 927} {Pfam: WSC domain [PF01822.21, score=41.8]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=50.1, Expect=1e-06]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=49.7, Expect=9e-07]; ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=47.8, Expect=4e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=62.0, Expect=6e-11]} {RNA1310_39527} {RNA815_19067} |
26. | MligTC455_42513 | 70 | 1.45 | Mlig455_023063, Mlig455_023065 | Neo: - Age: - |
KCNC2 | 2.802 | - | - | - | 0.915 | 0.901 | 0.986 | Mlig455_023063 {REF} {Length: 2276} {Pfam: Ion transport protein [PF00520.33, score=123.8]; BTB/POZ domain [PF02214.24, score=86.7]; Ion channel [PF07885.18, score=37.0]} {Human: ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=284, Expect=7e-87]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=280, Expect=4e-85]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=271, Expect=2e-81]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=279, Expect=4e-85]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=271, Expect=3e-81]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=285, Expect=3e-87]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=303, Expect=4e-94]} {Smed: dd_Smed_v6_13250_0_2, dd_Smed_v6_13250_0_2, [Score=286, Expect=3e-88]} {RNA1509_33421} {RNA1310_15684} {RNA815_16308} Mlig455_023065 {REF} {Length: 2276} {Pfam: Ion transport protein [PF00520.33, score=123.8]; BTB/POZ domain [PF02214.24, score=86.7]; Ion channel [PF07885.18, score=37.0]} {Human: ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=284, Expect=7e-87]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=280, Expect=4e-85]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=271, Expect=2e-81]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=279, Expect=4e-85]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=271, Expect=3e-81]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=285, Expect=3e-87]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=303, Expect=4e-94]} {Smed: dd_Smed_v6_13250_0_2, dd_Smed_v6_13250_0_2, [Score=286, Expect=3e-88]} {RNA1509_33421} {RNA1310_15684} {RNA815_16308} |
27. | MligTC455_24302 | 149 | 3.11 | Mlig455_035632 | Neo: - Age: Up-Down-Up |
KCNQ5 | 2.766 | - | - | - | 0.925 | 0.869 | 0.972 | Mlig455_035632 {REF} {Length: 2263} {Pfam: KCNQ voltage-gated potassium channel [PF03520.16, score=124.6]} {Human: ENSG00000185760, KCNQ5, potassium voltage-gated channel subfamily Q member 5, [Score=122, Expect=1e-28]; ENSG00000117013, KCNQ4, potassium voltage-gated channel subfamily Q member 4, [Score=121, Expect=2e-28]} {Mouse: ENSMUSG00000028033, Kcnq5, potassium voltage-gated channel, subfamily Q, member 5, [Score=121, Expect=1e-28]; ENSMUSG00000028631, Kcnq4, potassium voltage-gated channel, subfamily Q, member 4, [Score=119, Expect=4e-28]} {Dmel: FBgn0033494, KCNQ, KCNQ potassium channel, [Score=175, Expect=1e-46]} {Celegans: WBGene00002235, kqt-3, KQT-3 potassium channel; Potassium channel, KvQLT family, [Score=110, Expect=1e-25]} {Smed: dd_Smed_v6_17359_0_2, dd_Smed_v6_17359_0_2, [Score=186, Expect=2e-52]} {RNA1509_34272} {RNA1310_3730.1} {RNA815_2787} |
28. | MligTC455_50014 | 27 | 0.56 | Mlig455_003397 | Neo: - Age: - Region-enriched R2: 6.842/0.00677 |
2.76 | - | 0.961 | - | - | 0.906 | 0.893 | Mlig455_003397 {REF} {Length: 602} {NoTransDecoderORF} {RNA1310_99134} | |
29. | MligTC455_26765 | 686 | 14.29 | Mlig455_006971 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.201/0.00046 |
2.758 | - | 0.877 | - | - | 0.908 | 0.973 | Mlig455_006971 {REF} {Length: 6360} {Pfam: Cadherin domain [PF00028.19, score=29.2]} {Smed: dd_Smed_v6_10627_0_1, dd_Smed_v6_10627_0_1, [RH, Score=328, Expect=1e-93]} {RNA1509_19813, RNA1509_5311} {RNA1310_621, RNA1509_19813, RNA1509_5311} {RNA1509_19813, RNA1509_5311, RNA815_183.1} | |
30. | MligTC455_26766 | 638 | 13.3 | Mlig455_017977 | Neo: - Age: Up-Down-Down Region-specific R2: 4.360 Region-enriched R2: 3.395/0.00052 |
2.756 | - | 0.873 | - | - | 0.911 | 0.972 | Mlig455_017977 {REF} {Length: 2516} {Smed: dd_Smed_v6_10627_0_1, dd_Smed_v6_10627_0_1, [Score=249, Expect=3e-71]} {RNA1509_19813} {RNA1310_621} {RNA815_183.1} | |
31. | MligTC455_24061 | 1104 | 23.01 | Mlig455_017234 | Neo: - Age: - |
SNAP25 | 2.748 | - | - | - | 0.853 | 0.965 | 0.930 | Mlig455_017234 {REF} {Length: 1658} {Pfam: SNAP-25 family [PF00835.21, score=41.5]} {Human: ENSG00000132639, SNAP25, synaptosome associated protein 25, [Score=219, Expect=7e-72]} {Mouse: ENSMUSG00000027273, Snap25, synaptosomal-associated protein 25, [Score=219, Expect=5e-72]} {Dmel: FBgn0266720, Snap24, Synaptosomal-associated protein 24kDa, [RH, Score=228, Expect=1e-75]} {Celegans: WBGene00004364, ric-4, Synaptosomal-associated protein, [RH, Score=257, Expect=2e-87]} {Smed: dd_Smed_v6_3977_0_1, dd_Smed_v6_3977_0_1, [RH, Score=282, Expect=2e-97]} {RNA1509_25321, RNA1509_8624} {RNA1310_24253, RNA1509_25321, RNA1509_8624} {RNA1509_25321, RNA1509_8624, RNA815_10439} |
32. | MligTC455_52570 | 71 | 1.49 | Mlig455_066071 | Neo: - Age: Up-Down-Up |
2.747 | - | 0.944 | - | - | 0.837 | 0.966 | Mlig455_066071 {REF} {Length: 2575} {Pfam: Hemingway/CFA97 [PF13879.8, score=54.6]; Annexin [PF00191.22, score=26.1]} {Mouse: ENSMUSG00000090336, Cfap97d2, CFAP97 domain containing 2, [Score=46.6, Expect=3e-06]} {Smed: dd_Smed_v6_2676_0_1, dd_Smed_v6_2676_0_1, [Score=70.1, Expect=2e-13]} {RNA1310_29320.1} {RNA815_54680} | |
33. | MligTC455_23278 | 386 | 8.04 | Mlig455_037778 | Neo: - Age: logFC(26M/2M)=-0.605 |
SLC13A3 | 2.732 | - | - | - | 0.915 | 0.837 | 0.980 | Mlig455_037778 {REF} {Length: 3476} {Pfam: Sodium:sulfate symporter transmembrane region [PF00939.21, score=294.2]; Citrate transporter [PF03600.18, score=99.7]} {Human: ENSG00000158296, SLC13A3, solute carrier family 13 member 3, [Score=377, Expect=4e-121]} {Mouse: ENSMUSG00000018459, Slc13a3, solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3, [Score=367, Expect=1e-117]; ENSMUSG00000001095, Slc13a2, solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2, [Score=359, Expect=9e-115]} {Dmel: FBgn0036816, Indy, I'm not dead yet, [Score=175, Expect=1e-46]} {Celegans: WBGene00007138, B0285.6, Uncharacterized transporter B0285.6, [Score=194, Expect=2e-53]} {Smed: dd_Smed_v6_5476_0_1, dd_Smed_v6_5476_0_1, [Score=315, Expect=3e-98]} {RNA1509_1723, RNA1509_48306} {RNA1310_5497, RNA1509_48306} {RNA1509_48306, RNA815_1709} |
34. | MligTC455_40654 | 676 | 14.08 | Mlig455_056785 | Neo: - Age: logFC(26M/2M)=-0.402 |
CCDC63 | 2.73 | - | - | - | 0.896 | 0.866 | 0.968 | Mlig455_056785 {REF} {Length: 2093} {TRANSSPLICED} {Pfam: Initiation control protein YabA [PF06156.15, score=20.5]} {Human: ENSG00000173093, CCDC63, coiled-coil domain containing 63, [RH, Score=190, Expect=9e-53]} {Mouse: ENSMUSG00000043036, Ccdc63, coiled-coil domain containing 63, [RH, Score=179, Expect=7e-49]} {Dmel: FBgn0038452, CG14905, [RH, Score=168, Expect=6e-46]} {Smed: dd_Smed_v6_4191_0_1, dd_Smed_v6_4191_0_1, [RH, Score=442, Expect=7e-150]} {RNA1509_17628} {RNA1310_12386, RNA1509_17628} {RNA1509_17628, RNA815_7054} |
35. | MligTC455_29914 | 44 | 0.91 | Mlig455_027923 | Neo: - Age: Down-Up-Down Region-enriched R2: 8.096/0.00455 |
ANGPTL3 | 2.71 | - | 0.831 | - | - | 0.910 | 0.969 | Mlig455_027923 {REF} {Length: 1663} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=70.5]} {Human: ENSG00000132855, ANGPTL3, angiopoietin like 3, [Score=60.5, Expect=9e-10]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=59.3, Expect=2e-09]; ENSG00000120332, TNN, tenascin N, [Score=58.9, Expect=3e-09]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=62.4, Expect=2e-10]} {Dmel: FBgn0031804, CG9500, [Score=76.3, Expect=6e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=51.2, Expect=3e-07]} {RNA1509_53291} {RNA1310_58974} {RNA815_43288.3} |
36. | MligTC455_41396 | 187 | 3.9 | Mlig455_012937, Mlig455_031470 | Neo: - Age: - Region-enriched R2: 4.167/0.01146 |
2.706 | - | 0.852 | - | - | 0.881 | 0.973 | Mlig455_012937 {REF} {Length: 1911} {Smed: dd_Smed_v6_11196_0_1, dd_Smed_v6_11196_0_1, [Score=46.6, Expect=1e-06]} {RNA1509_16138} {RNA1310_24329} {RNA815_11818} Mlig455_031470 {REF} {Length: 1745} {Dmel: FBgn0083971, CG34135, [RH, Score=60.1, Expect=1e-10]} {Smed: dd_Smed_v6_11196_0_1, dd_Smed_v6_11196_0_1, [RH, Score=96.3, Expect=3e-23]} {RNA1509_16138} {RNA1310_24329} {RNA815_11818} |
|
37. | MligTC455_32165 | 302 | 6.3 | Mlig455_028110, Mlig455_045231, Mlig455_069146 | Neo: - Age: - |
2.696 | - | - | - | 0.961 | 0.780 | 0.955 | Mlig455_028110 {REF} {Length: 668} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=31.4]; PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=19.9]} {Smed: dd_Smed_v6_7982_0_1, dd_Smed_v6_7982_0_1, [Score=69.7, Expect=4e-14]} {RNA1310_31139.2} {RNA815_42018} Mlig455_045231 {REF} {Length: 2983} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=46.7]} {Smed: dd_Smed_v6_7982_0_1, dd_Smed_v6_7982_0_1, [RH, Score=115, Expect=4e-29]} {RNA1509_55345} {RNA1310_31139.1} {RNA815_42018} Mlig455_069146 {REF} {Length: 1639} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=40.1]} {Smed: dd_Smed_v6_16515_0_1, dd_Smed_v6_16515_0_1, [RH, Score=99.0, Expect=7e-25]} {RNA1310_31190} {RNA815_42018} |
|
38. | MligTC455_42646 | 265 | 5.53 | Mlig455_046692 | Neo: - Age: - Region-enriched R2: 2.509/0.02015 |
KRT8 | 2.694 | - | - | - | 0.823 | 0.979 | 0.892 | Mlig455_046692 {REF} {Length: 3581} {TRANSSPLICED} {Pfam: Intermediate filament protein [PF00038.23, score=144.4]; Protein of unknown function (DUF3450) [PF11932.10, score=22.6]; BRE1 E3 ubiquitin ligase [PF08647.13, score=19.7]; Bacillus haemolytic enterotoxin (HBL) [PF05791.13, score=18.9]; Afadin- and alpha -actinin-Binding [PF11559.10, score=18.7]; Crescentin protein [PF19220.2, score=18.6]} {Human: ENSG00000170421, KRT8, keratin 8, [RH, Score=111, Expect=2e-25]} {Mouse: ENSMUSG00000063661, Krt73, keratin 73, [RH, Score=107, Expect=3e-24]} {Dmel: FBgn0010397, LamC, Lamin C, [Score=140, Expect=4e-35]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [Score=251, Expect=7e-76]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [Score=275, Expect=4e-85]} {RNA1310_10400} {RNA815_12264} |
39. | MligTC455_19277 | 1013 | 21.11 | Mlig455_059600 | Neo: - Age: - Region-specific R2: 4.883 Region-enriched R2: 5.766/0.00000 |
2.693 | - | 0.755 | - | - | 0.963 | 0.975 | Mlig455_059600 {REF} {Length: 827} {NoTransDecoderORF} {RNA1509_43907} {RNA1310_81348} | |
40. | MligTC455_32164 | 149 | 3.11 | Mlig455_028109 | Neo: - Age: - |
2.684 | - | - | - | 0.960 | 0.779 | 0.945 | Mlig455_028109 {REF} {Length: 205} {NoTransDecoderORF} {RNA1310_31190} {RNA815_49804} | |
41. | MligTC455_49491 | 136 | 2.83 | Mlig455_054796 | Neo: - Age: - Region-enriched R2: 7.065/0.00003 |
2.683 | - | - | - | 0.777 | 0.935 | 0.971 | Mlig455_054796 {REF} {Length: 1567} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
42. | MligTC455_35895 | 102 | 2.12 | Mlig455_063971 | Neo: - Age: - |
RYK | 2.681 | - | - | - | 0.851 | 0.853 | 0.977 | Mlig455_063971 {REF} {Length: 3496} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=209.4]; WIF domain [PF02019.20, score=109.7]; Protein kinase domain [PF00069.27, score=79.1]} {Human: ENSG00000163785, RYK, receptor-like tyrosine kinase, [Score=202, Expect=1e-55]} {Mouse: ENSMUSG00000032547, Ryk, receptor-like tyrosine kinase, [RH, Score=202, Expect=2e-55]} {Dmel: FBgn0015380, drl, derailed, [RH, Score=239, Expect=4e-69]} {Celegans: WBGene00003007, lin-18, Inactive tyrosine-protein kinase RYK, [Score=179, Expect=6e-48]} {Smed: dd_Smed_v6_12594_0_2, dd_Smed_v6_12594_0_2, [Score=201, Expect=3e-55]} {RNA1509_58811} {RNA1310_6671.2} {RNA815_41921} |
43. | MligTC455_39957 | 170 | 3.54 | Mlig455_039809 | Neo: - Age: - Region-specific R2: 4.733 Region-enriched R2: 5.232/0.00000 |
ADGB | 2.676 | - | - | - | 0.834 | 0.879 | 0.963 | Mlig455_039809 {REF} {Length: 7010} {tRNA: Ile(TAT),pseudo, score=33.4} {Pfam: Calpain family cysteine protease [PF00648.23, score=34.1]} {Human: ENSG00000118492, ADGB, androglobin, [Score=403, Expect=6e-115]} {Mouse: ENSMUSG00000050994, Adgb, androglobin, [Score=252, Expect=4e-67]} {Celegans: WBGene00000543, clp-2, CaLPain family, [Score=73.2, Expect=1e-12]} {Smed: dd_Smed_v6_10677_0_1, dd_Smed_v6_10677_0_1, [Score=253, Expect=8e-68]} {RNA1509_15950, RNA1509_59203} {RNA1310_4821, RNA1509_59203} {RNA1509_59203, RNA815_12506} |
44. | MligTC455_29049 | 441 | 9.18 | Mlig455_042244 | Neo: - Age: - Region-enriched R2: 4.677/0.00000 |
RASGRF1 | 2.673 | - | 0.776 | - | - | 0.960 | 0.937 | Mlig455_042244 {REF} {Length: 6465} {Pfam: RasGEF domain [PF00617.21, score=193.2]; RhoGEF domain [PF00621.22, score=119.3]; PH domain [PF00169.31, score=86.7]; RasGEF N-terminal motif [PF00618.22, score=68.4]; Pleckstrin homology domain [PF15413.8, score=22.6]} {Human: ENSG00000058335, RASGRF1, Ras protein specific guanine nucleotide releasing factor 1, [RH, Score=763, Expect=0.0]; ENSG00000113319, RASGRF2, Ras protein specific guanine nucleotide releasing factor 2, [RH, Score=739, Expect=0.0]} {Mouse: ENSMUSG00000032356, Rasgrf1, RAS protein-specific guanine nucleotide-releasing factor 1, [RH, Score=763, Expect=0.0]} {Dmel: FBgn0001965, Sos, Son of sevenless, [Score=164, Expect=3e-40]} {Celegans: WBGene00004947, sos-1, Son of sevenless homolog, [Score=118, Expect=3e-26]} {Smed: dd_Smed_v6_18313_0_2, dd_Smed_v6_18313_0_2, [RH, Score=1137, Expect=0.0]} {RNA1509_15697} {RNA1310_2543.1} {RNA815_8228.1} |
45. | MligTC455_33463 | 240 | 4.99 | Mlig455_023684 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.110/0.00054 |
PKD1L2 | 2.67 | - | - | - | 0.803 | 0.892 | 0.975 | Mlig455_023684 {REF} {Length: 12137} {Pfam: Polycystin cation channel [PF08016.14, score=271.5]; PKD domain [PF00801.22, score=88.3]; PLAT/LH2 domain [PF01477.25, score=72.6]; PKD domain [PF18911.2, score=49.9]; Ion transport protein [PF00520.33, score=46.0]; F5/8 type C domain [PF00754.27, score=33.9]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [RH, Score=263, Expect=2e-69]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=272, Expect=3e-72]} {Dmel: FBgn0050048, CG30048, [Score=57.4, Expect=3e-07]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=144, Expect=2e-33]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=518, Expect=3e-147]} {RNA1509_5488} {RNA1310_100} {RNA815_3211} |
46. | MligTC455_40119 | 114 | 2.37 | Mlig455_034596 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.158/0.00258 |
KCNIP1 | 2.667 | - | - | - | 0.891 | 0.801 | 0.975 | Mlig455_034596 {REF} {Length: 1987} {Pfam: EF-hand domain pair [PF13499.8, score=42.4]; EF hand [PF00036.34, score=38.6]; EF-hand domain [PF13405.8, score=33.5]; EF hand [PF13202.8, score=31.2]; EF-hand domain pair [PF13833.8, score=28.7]} {Human: ENSG00000182132, KCNIP1, potassium voltage-gated channel interacting protein 1, [Score=122, Expect=3e-32]; ENSG00000185774, KCNIP4, potassium voltage-gated channel interacting protein 4, [Score=122, Expect=2e-32]; ENSG00000115041, KCNIP3, potassium voltage-gated channel interacting protein 3, [Score=119, Expect=1e-30]} {Mouse: ENSMUSG00000053519, Kcnip1, Kv channel-interacting protein 1, [Score=124, Expect=5e-33]; ENSMUSG00000029088, Kcnip4, Kv channel interacting protein 4, [Score=122, Expect=1e-32]} {Dmel: FBgn0013303, Nca, Neurocalcin, [Score=100, Expect=6e-25]} {Celegans: WBGene00003563, ncs-1, Neuronal calcium sensor 1, [Score=103, Expect=6e-26]} {Smed: dd_Smed_v6_9727_0_1, dd_Smed_v6_9727_0_1, [Score=122, Expect=7e-33]} {RNA1310_43225} {RNA815_33406} |
47. | MligTC455_17412 | 44 | 0.91 | Mlig455_069737 | Neo: - Age: - Region-enriched R2: 5.062/0.00923 |
2.666 | - | - | 0.847 | - | 0.868 | 0.951 | Mlig455_069737 {REF} {Length: 1628} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=42.8]} {Smed: dd_Smed_v6_31564_0_1, dd_Smed_v6_31564_0_1, [Score=72.8, Expect=3e-14]} {RNA1310_45758} {RNA815_42912} | |
48. | MligTC455_40353 | 39 | 0.82 | Mlig455_024525 | Neo: - Age: - |
2.665 | - | 0.870 | - | - | 0.834 | 0.961 | Mlig455_024525 {REF} {Length: 1158} {RNA1310_29008} | |
49. | MligTC455_47261 | 1918 | 39.96 | Mlig455_033946 | Neo: - Age: - Region-specific R2: 4.808 Region-enriched R2: 4.545/0.00000 |
2.661 | - | - | - | 0.798 | 0.904 | 0.959 | Mlig455_033946 {REF} {Length: 2098} {RNA1509_18239, RNA1509_26992, RNA1509_32368} {RNA1310_36725.1, RNA1509_18239, RNA1509_26992, RNA1509_32368} {RNA1509_18239, RNA1509_26992, RNA1509_32368, RNA815_10268.1} | |
50. | MligTC455_31058 | 105 | 2.19 | Mlig455_055504 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.938/0.00376 |
2.659 | - | - | - | 0.752 | 0.957 | 0.950 | Mlig455_055504 {REF} {Length: 2826} {RNA1509_37722} {RNA1310_40193} {RNA815_29874} | |
51. | MligTC455_15492 | 69 | 1.44 | Mlig455_022488 | Neo: - Age: Down-Up-Up |
2.647 | - | - | - | 0.711 | 0.956 | 0.980 | Mlig455_022488 {REF} {Length: 1351} {RNA1310_26051} {RNA815_10966} | |
52. | MligTC455_33040 | 203 | 4.23 | Mlig455_032497 | Neo: - Age: logFC(26M/2M)=0.515 Region-enriched R2: 4.005/0.00408 |
PKD2L1 | 2.644 | - | - | - | 0.749 | 0.953 | 0.942 | Mlig455_032497 {REF} {Length: 3318} {Pfam: Polycystin cation channel [PF08016.14, score=293.1]; Ion transport protein [PF00520.33, score=39.7]} {Human: ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [Score=236, Expect=4e-66]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=261, Expect=3e-73]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=131, Expect=5e-31]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=180, Expect=1e-47]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=641, Expect=0.0]} {RNA1509_3444} {RNA1310_89} {RNA815_1814} |
53. | MligTC455_35019 | 168 | 3.49 | Mlig455_046994 | Neo: - Age: - |
ASIC4 | 2.643 | - | - | - | 0.828 | 0.864 | 0.951 | Mlig455_046994 {REF} {Length: 4001} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=101.4]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=76.3, Expect=1e-13]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=76.3, Expect=8e-14]; ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=72.8, Expect=8e-13]} {Smed: dd_Smed_v6_15233_0_1, dd_Smed_v6_15233_0_1, [RH, Score=103, Expect=1e-22]} {RNA1509_33816} {RNA1310_3176, RNA1509_33816} {RNA1509_33816, RNA815_12439} |
54. | MligTC455_44195 | 267 | 5.56 | Mlig455_057666 | Neo: - Age: logFC(26M/2M)=0.586 Region-enriched R2: 4.885/0.00002 |
2.638 | - | 0.749 | - | - | 0.911 | 0.978 | Mlig455_057666 {REF} {Length: 1757} {RNA1509_45654, RNA1509_50922} {RNA1310_26801.2, RNA1509_45654, RNA1509_50922} {RNA1509_45654, RNA1509_50922, RNA815_13136} | |
55. | MligTC455_36730 | 165 | 3.44 | Mlig455_056961 | Neo: - Age: Up-Down-Down |
2.634 | - | 0.855 | - | - | 0.829 | 0.950 | Mlig455_056961 {REF} {Length: 4865} {Pfam: Lipoma HMGIC fusion partner-like protein [PF10242.11, score=57.3]} {RNA1310_49374} {RNA815_39552} | |
56. | MligTC455_15330 | 373 | 7.77 | Mlig455_020220 | Neo: - |
2.626 | - | - | - | 0.751 | 0.906 | 0.969 | Mlig455_020220 {REF} {Length: 2115} {Pfam: Fas apoptotic inhibitory molecule (FAIM1) [PF06905.15, score=41.4]} {Smed: dd_Smed_v6_4798_0_1, dd_Smed_v6_4798_0_1, [RH, Score=82.0, Expect=3e-20]} {RNA1509_28885, RNA1509_54654} {RNA1310_42962.2, RNA1509_28885, RNA1509_54654} {RNA1509_28885, RNA1509_54654, RNA815_23071} | |
57. | MligTC455_33832 | 112 | 2.34 | Mlig455_029411 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.300/0.00016 |
GLRA3 | 2.625 | - | - | - | 0.780 | 0.875 | 0.970 | Mlig455_029411 {REF} {Length: 3686} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=84.5]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=257, Expect=5e-80]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=253, Expect=3e-78]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=250, Expect=4e-77]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=251, Expect=2e-77]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=249, Expect=5e-77]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=2e-76]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=243, Expect=1e-74]} {Dmel: FBgn0024963, GluClalpha, [Score=253, Expect=2e-78]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=259, Expect=7e-81]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [RH, Score=480, Expect=1e-167]} {RNA1509_35986} {RNA1310_35528} {RNA815_35433} |
58. | MligTC455_21720 | 323 | 6.72 | Mlig455_036807 | Neo: - Age: logFC(26M/2M)=-0.580 |
TRPM3 | 2.62 | - | - | - | 0.736 | 0.917 | 0.967 | Mlig455_036807 {REF} {Length: 4421} {TRANSSPLICED} {Pfam: SLOG in TRPM [PF18139.3, score=221.7]; SLOG in TRPM, prokaryote [PF18171.3, score=67.4]; Ion transport protein [PF00520.33, score=52.8]} {Human: ENSG00000083067, TRPM3, transient receptor potential cation channel subfamily M member 3, [RH, Score=517, Expect=1e-156]} {Mouse: ENSMUSG00000052387, Trpm3, transient receptor potential cation channel, subfamily M, member 3, [RH, Score=518, Expect=3e-157]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=482, Expect=5e-149]} {Celegans: WBGene00001796, gtl-2, Gon-Two Like (TRP subfamily), [Score=363, Expect=2e-104]} {Smed: dd_Smed_v6_13119_0_1, dd_Smed_v6_13119_0_1, [Score=604, Expect=0.0]} {RNA1509_4847} {RNA1310_1801.1} {RNA815_652.1} |
59. | MligTC455_48022 | 1337 | 27.86 | Mlig455_045267, Mlig455_069186 | Neo: - Age: - Region-enriched R2: 2.130/0.00146 |
2.619 | - | 0.816 | - | - | 0.957 | 0.846 | Mlig455_045267 {REF} {Length: 3628} {Pfam: Ankyrin repeats (many copies) [PF13857.8, score=29.5]; Ankyrin repeats (many copies) [PF13637.8, score=28.4]; Ankyrin repeats (3 copies) [PF12796.9, score=28.3]; Ankyrin repeat [PF13606.8, score=23.5]} {Celegans: WBGene00009375, F34D10.6, [Score=57.0, Expect=6e-08]} {Smed: dd_Smed_v6_5594_0_3, dd_Smed_v6_5594_0_3, [Score=58.5, Expect=1e-08]} {RNA1509_17412, RNA1509_32079} {RNA1310_5952, RNA1509_17412, RNA1509_32079} {RNA1509_17412, RNA1509_32079, RNA815_2323} Mlig455_069186 {REF} {Length: 3598} {Pfam: Ankyrin repeats (many copies) [PF13637.8, score=30.4]; Ankyrin repeats (3 copies) [PF12796.9, score=30.1]; Ankyrin repeats (many copies) [PF13857.8, score=29.5]; Ankyrin repeat [PF13606.8, score=24.1]} {Celegans: WBGene00009375, F34D10.6, [Score=56.6, Expect=6e-08]} {Smed: dd_Smed_v6_5594_0_4, dd_Smed_v6_5594_0_4, [Score=59.3, Expect=7e-09]} {RNA1509_52963} {RNA1310_5952, RNA1509_52963} {RNA1509_52963, RNA815_2323} |
|
60. | MligTC455_19275 | 407 | 8.47 | Mlig455_037548 | Neo: - Age: logFC(26M/2M)=0.488 Region-enriched R2: 3.247/0.04164 |
CHRNA10 | 2.613 | - | - | - | 0.765 | 0.953 | 0.895 | Mlig455_037548 {REF} {Length: 959} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=87.9]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=96.7, Expect=1e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=97.1, Expect=7e-23]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=95.1, Expect=5e-22]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=1e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=119, Expect=8e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=93.2, Expect=1e-21]} {RNA1509_23115} {RNA1310_34970} {RNA815_15305.1} |
61. | MligTC455_53844 | 1403 | 29.24 | Mlig455_051626 | Neo: - |
2.611 | - | - | - | 0.768 | 0.888 | 0.955 | Mlig455_051626 {REF} {Length: 1671} {RNA1509_15580} {RNA1310_24090} {RNA815_10676.2} | |
62. | MligTC455_32922 | 646 | 13.45 | Mlig455_037744, Mlig455_069919 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.335 Region-enriched R2: 1.859/0.01146 |
ANXA4 | 2.609 | - | - | - | 0.803 | 0.847 | 0.959 | Mlig455_037744 {REF} {Length: 3044} {TRANSSPLICED} {Pfam: Annexin [PF00191.22, score=312.1]; Fn3 associated [PF13287.8, score=30.9]; Chitobiase/beta-hexosaminidase C-terminal domain [PF13290.8, score=27.1]} {Human: ENSG00000196975, ANXA4, annexin A4, [RH, Score=330, Expect=1e-106]; ENSG00000122359, ANXA11, annexin A11, [RH, Score=318, Expect=6e-100]} {Mouse: ENSMUSG00000029994, Anxa4, annexin A4, [RH, Score=328, Expect=2e-106]; ENSMUSG00000021866, Anxa11, annexin A11, [RH, Score=317, Expect=2e-99]} {Dmel: FBgn0030749, AnxB11, Annexin B11, [RH, Score=318, Expect=6e-100]} {Celegans: WBGene00003589, nex-2, Annexin, [RH, Score=298, Expect=7e-93]} {Smed: dd_Smed_v6_5798_0_1, dd_Smed_v6_5798_0_1, [RH, Score=726, Expect=0.0]} {RNA1509_19722} {RNA1310_5582} {RNA815_3942.1} Mlig455_069919 {REF} {Length: 3044} {TRANSSPLICED} {Pfam: Annexin [PF00191.22, score=308.6]; Fn3 associated [PF13287.8, score=30.9]; Chitobiase/beta-hexosaminidase C-terminal domain [PF13290.8, score=27.1]} {Human: ENSG00000196975, ANXA4, annexin A4, [RH, Score=330, Expect=6e-107]; ENSG00000122359, ANXA11, annexin A11, [RH, Score=316, Expect=3e-99]} {Mouse: ENSMUSG00000029994, Anxa4, annexin A4, [RH, Score=329, Expect=1e-106]; ENSMUSG00000021866, Anxa11, annexin A11, [RH, Score=315, Expect=1e-98]} {Dmel: FBgn0030749, AnxB11, Annexin B11, [RH, Score=316, Expect=3e-99]} {Celegans: WBGene00003589, nex-2, Annexin, [RH, Score=297, Expect=3e-92]} {Smed: dd_Smed_v6_5798_0_1, dd_Smed_v6_5798_0_1, [RH, Score=726, Expect=0.0]} {RNA1509_19722, RNA1509_52903} {RNA1310_5582, RNA1509_19722, RNA1509_52903} {RNA1509_19722, RNA1509_52903, RNA815_3942.1} |
63. | MligTC455_51764 | 938 | 19.55 | Mlig455_016061 | Neo: - Age: - Region-specific R2: 2.881 Region-enriched R2: 1.672/0.00180 |
2.608 | - | 0.801 | - | - | 0.852 | 0.955 | Mlig455_016061 {REF} {Length: 649} {RNA1509_58232} {RNA1310_60107.1, RNA1509_58232} {RNA1509_58232, RNA815_31573} | |
64. | MligTC455_37315 | 84 | 1.76 | Mlig455_048842 | Neo: - Age: - |
CALM2 | 2.606 | - | - | - | 0.846 | 0.802 | 0.958 | Mlig455_048842 {REF} {Length: 1287} {Pfam: EF-hand domain pair [PF13499.8, score=22.7]; EF-hand domain [PF14658.8, score=19.6]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=68.9, Expect=6e-14]; ENSG00000198668, CALM1, calmodulin 1, [Score=68.2, Expect=4e-14]; ENSG00000160014, CALM3, calmodulin 3, [Score=66.6, Expect=2e-13]; ENSG00000178363, CALML3, calmodulin like 3, [Score=65.5, Expect=4e-13]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=67.0, Expect=2e-13]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=66.6, Expect=1e-13]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=66.6, Expect=1e-13]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=68.6, Expect=1e-14]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=68.6, Expect=1e-14]} {Smed: dd_Smed_v6_5491_0_1, dd_Smed_v6_5491_0_1, [Score=110, Expect=3e-30]} {RNA1310_33365} {RNA815_27013} |
65. | MligTC455_08760 | 88 | 1.82 | Mlig455_032303 | Neo: - Age: - |
2.603 | - | - | - | 0.733 | 0.909 | 0.961 | Mlig455_032303 {REF} {Length: 746} {Pfam: WSC domain [PF01822.21, score=46.4]; PAN domain [PF00024.28, score=25.3]} {RNA1310_49278} {RNA815_40649} | |
66. | MligTC455_50927 | 254 | 5.29 | Mlig455_070541, Mlig455_070562 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.296 Region-enriched R2: 7.883/0.00008 |
FZD4 | 2.603 | - | 0.732 | - | - | 0.883 | 0.988 | Mlig455_070541 {REF} {Length: 3522} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=471, Expect=6e-159]} {RNA1509_15834} {RNA1310_3800, RNA1509_15834} {RNA1509_15834, RNA815_19571} Mlig455_070562 {REF} {Length: 3527} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=2e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=470, Expect=8e-159]} {RNA1509_15834} {RNA1310_3800} {RNA815_19571} |
67. | MligTC455_46395 | 870 | 18.13 | Mlig455_069471 | Neo: - Age: logFC(26M/2M)=0.458 |
PKD2 | 2.601 | - | 0.745 | - | - | 0.904 | 0.952 | Mlig455_069471 {REF} {Length: 3122} {TRANSSPLICED} {Pfam: Polycystin cation channel [PF08016.14, score=487.8]; Ion transport protein [PF00520.33, score=93.3]; EF hand [PF00036.34, score=32.7]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=21.3]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=753, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=750, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=323, Expect=1e-96]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=387, Expect=8e-123]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=769, Expect=0.0]} {RNA1509_13522} {RNA1310_21296.2} {RNA815_3158.1} |
68. | MligTC455_28488 | 229 | 4.78 | Mlig455_022492 | Neo: - |
FN1 | 2.596 | - | - | - | 0.744 | 0.966 | 0.886 | Mlig455_022492 {REF} {Length: 11261} {TRANSSPLICED} {Pfam: Fibronectin type III domain [PF00041.23, score=253.9]; Purple acid Phosphatase, N-terminal domain [PF16656.7, score=42.9]; Chitobiase/beta-hexosaminidase C-terminal domain [PF13290.8, score=32.7]; Interferon-alpha/beta receptor, fibronectin type III [PF09294.12, score=25.0]; Fn3 associated [PF13287.8, score=19.1]} {Human: ENSG00000115414, FN1, fibronectin 1, [Score=64.3, Expect=4e-09]} {Mouse: ENSMUSG00000026193, Fn1, fibronectin 1, [Score=67.8, Expect=2e-10]; ENSMUSG00000032332, Col12a1, collagen, type XII, alpha 1, [Score=65.1, Expect=1e-09]} {Smed: dd_Smed_v6_16808_0_1, dd_Smed_v6_16808_0_1, [RH, Score=759, Expect=0.0]} {RNA1509_2206, RNA1509_23145} {RNA1310_94.1, RNA1509_23145} {RNA1509_23145, RNA815_2164} |
69. | MligTC455_18564 | 196 | 4.08 | Mlig455_063527 | Neo: - Age: - Region-enriched R2: 2.416/0.01839 |
PRKG2 | 2.591 | - | - | - | 0.764 | 0.862 | 0.965 | Mlig455_063527 {REF} {Length: 2971} {Pfam: Protein kinase domain [PF00069.27, score=212.4]; Cyclic nucleotide-binding domain [PF00027.31, score=135.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=103.7]; Kinase-like [PF14531.8, score=24.8]} {Human: ENSG00000138669, PRKG2, protein kinase cGMP-dependent 2, [RH, Score=653, Expect=0.0]} {Mouse: ENSMUSG00000029334, Prkg2, protein kinase, cGMP-dependent, type II, [RH, Score=651, Expect=0.0]} {Dmel: FBgn0000442, Pkg21D, Protein kinase, cGMP-dependent at 21D, [RH, Score=662, Expect=0.0]} {Celegans: WBGene00001173, egl-4, cGMP-dependent protein kinase egl-4, [Score=655, Expect=0.0]} {Smed: dd_Smed_v6_6967_0_1, dd_Smed_v6_6967_0_1, [RH, Score=645, Expect=0.0]} {RNA1509_38353} {RNA1310_8466, RNA1509_38353} {RNA1509_38353, RNA815_6313} |
70. | MligTC455_24270 | 71 | 1.47 | Mlig455_005120 | Neo: - Age: - |
CHRNA7 | 2.582 | - | - | - | 0.709 | 0.886 | 0.987 | Mlig455_005120 {REF} {Length: 1530} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=66.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=148, Expect=4e-39]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=147, Expect=5e-39]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=146, Expect=2e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=1e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=135, Expect=5e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=9e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=133, Expect=4e-34]} {RNA1509_43533} {RNA1310_20839.2} {RNA815_22406} |
71. | MligTC455_42994 | 1521 | 31.7 | Mlig455_035840 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.356 Region-enriched R2: 1.854/0.00052 |
2.579 | - | - | - | 0.729 | 0.891 | 0.959 | Mlig455_035840 {REF} {Length: 1436} {RNA1509_29485, RNA1509_42231} {RNA1310_26640, RNA1509_29485, RNA1509_42231} {RNA1509_29485, RNA1509_42231, RNA815_37260} | |
72. | MligTC455_15679 | 88 | 1.82 | Mlig455_057219 | Neo: - Age: Down-Up-Up |
WSCD2 | 2.578 | - | - | - | 0.779 | 0.830 | 0.969 | Mlig455_057219 {REF} {Length: 1035} {Pfam: WSC domain [PF01822.21, score=55.1]; PAN domain [PF00024.28, score=27.0]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=52.8, Expect=2e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=51.6, Expect=3e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=53.5, Expect=5e-08]} {RNA1509_46267} {RNA1310_46146} {RNA815_32275.1} |
73. | MligTC455_24749 | 40 | 0.83 | Mlig455_016644 | Neo: - Age: - |
2.575 | - | - | 0.734 | - | 0.888 | 0.953 | Mlig455_016644 {REF} {Length: 1015} {Pfam: Lectin C-type domain [PF00059.23, score=20.4]; PAN domain [PF00024.28, score=18.8]} {Smed: dd_Smed_v6_85740_0_1, dd_Smed_v6_85740_0_1, [Score=60.5, Expect=1e-11]} {RNA1310_47779} {RNA815_39270} | |
74. | MligTC455_43741 | 196 | 4.08 | Mlig455_018088 | Neo: - Age: Down-Up-Down |
PTBP1 | 2.568 | - | - | - | 0.760 | 0.847 | 0.961 | Mlig455_018088 {REF} {Length: 2775} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF13893.8, score=116.9]; RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=52.7]; Occluded RNA-recognition motif [PF16842.7, score=26.8]} {Human: ENSG00000011304, PTBP1, polypyrimidine tract binding protein 1, [Score=258, Expect=8e-80]; ENSG00000117569, PTBP2, polypyrimidine tract binding protein 2, [Score=258, Expect=1e-80]; ENSG00000119314, PTBP3, polypyrimidine tract binding protein 3, [Score=248, Expect=1e-76]} {Mouse: ENSMUSG00000028134, Ptbp2, polypyrimidine tract binding protein 2, [Score=258, Expect=7e-81]; ENSMUSG00000006498, Ptbp1, polypyrimidine tract binding protein 1, [Score=251, Expect=1e-78]; ENSMUSG00000028382, Ptbp3, polypyrimidine tract binding protein 3, [Score=248, Expect=1e-77]} {Dmel: FBgn0011224, heph, hephaestus, [Score=249, Expect=7e-78]} {Celegans: WBGene00004207, ptb-1, PTB (HnRNP) homolog; Putative RNA-binding protein PTB-1b, [Score=234, Expect=1e-72]} {Smed: dd_Smed_v6_1868_0_1, dd_Smed_v6_1868_0_1, [Score=214, Expect=4e-64]} {RNA1509_36451} {RNA1310_3345} {RNA815_23519} |
75. | MligTC455_49877 | 188 | 3.91 | Mlig455_027465 | Neo: - Age: - Region-enriched R2: 3.005/0.04141 |
AC254952.1 | 2.559 | - | - | - | 0.727 | 0.878 | 0.954 | Mlig455_027465 {REF} {Length: 2059} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=89.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=80.0]} {Human: ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=6e-38]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=144, Expect=1e-37]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=144, Expect=1e-37]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=144, Expect=9e-38]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=141, Expect=2e-36]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=141, Expect=1e-36]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=141, Expect=6e-37]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=139, Expect=5e-36]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=134, Expect=2e-34]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=132, Expect=4e-33]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=126, Expect=6e-32]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=131, Expect=2e-33]} {RNA1310_26175} {RNA815_7952} |
76. | MligTC455_53842 | 1222 | 25.46 | Mlig455_023890 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.345 Region-enriched R2: 1.546/0.01667 |
2.559 | - | - | - | 0.775 | 0.811 | 0.973 | Mlig455_023890 {REF} {Length: 1336} {RNA1509_15580} {RNA1310_22487.1} {RNA815_10676.1} | |
77. | MligTC455_35583 | 48 | 0.99 | Mlig455_009953 | Neo: - Age: - |
2.558 | - | - | - | 0.719 | 0.875 | 0.964 | Mlig455_009953 {REF} {Length: 919} {Pfam: Lectin C-type domain [PF00059.23, score=25.9]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=61.6, Expect=2e-11]} {RNA1509_20946} {RNA1310_71370} {RNA815_4785.4} | |
78. | MligTC455_54282 | 74 | 1.54 | Mlig455_020191 | Neo: - Age: - |
2.556 | - | - | - | 0.755 | 0.815 | 0.986 | Mlig455_020191 {REF} {Length: 937} {RNA1509_48973} {RNA1310_40738.2} {RNA815_31898} | |
79. | MligTC455_19279 | 4576 | 95.33 | Mlig455_057411 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.654 Region-specific R2: 5.173 Region-enriched R2: 4.585/0.00000 |
CHRNA10 | 2.55 | - | - | - | 0.730 | 0.844 | 0.976 | Mlig455_057411 {REF} {Length: 1075} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=85.3]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=91.3, Expect=1e-20]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=92.0, Expect=7e-21]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=88.2, Expect=1e-19]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=2e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=120, Expect=4e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=96.3, Expect=8e-23]} {RNA1509_1306} {RNA1310_34970} {RNA815_15305.1} |
80. | MligTC455_39988 | 83 | 1.73 | Mlig455_062081 | Neo: - Age: - |
2.547 | - | - | - | 0.783 | 0.792 | 0.972 | Mlig455_062081 {REF} {Length: 447} {NoTransDecoderORF} {RNA1509_50426} {RNA1310_88257} {RNA815_17173.4} | |
81. | MligTC455_09455 | 51 | 1.06 | Mlig455_029990 | Neo: - Age: - Region-enriched R2: 4.710/0.00601 |
2.537 | - | - | 0.794 | - | 0.792 | 0.951 | Mlig455_029990 {REF} {Length: 3817} {Mouse: ENSMUSG00000090546, Cdr1, cerebellar degeneration related antigen 1, [Score=63.2, Expect=8e-10]} {Celegans: WBGene00013762, Y113G7B.12, [Score=58.2, Expect=2e-08]} {RNA1509_44134} {RNA1310_28496} {RNA815_11143} | |
82. | MligTC455_46305 | 450 | 9.39 | Mlig455_047530 | Neo: - Age: Down-Up-Down |
PTBP3 | 2.526 | - | 0.734 | - | 0.838 | - | 0.954 | Mlig455_047530 {REF} {Length: 3409} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF13893.8, score=152.2]; RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=112.0]; RRM-like domain [PF11835.10, score=52.5]; Occluded RNA-recognition motif [PF16842.7, score=43.9]; RNA binding motif [PF08777.13, score=18.6]} {Human: ENSG00000119314, PTBP3, polypyrimidine tract binding protein 3, [RH, Score=466, Expect=9e-157]; ENSG00000117569, PTBP2, polypyrimidine tract binding protein 2, [RH, Score=465, Expect=1e-156]; ENSG00000011304, PTBP1, polypyrimidine tract binding protein 1, [RH, Score=464, Expect=7e-156]} {Mouse: ENSMUSG00000028382, Ptbp3, polypyrimidine tract binding protein 3, [RH, Score=468, Expect=7e-158]; ENSMUSG00000006498, Ptbp1, polypyrimidine tract binding protein 1, [RH, Score=468, Expect=8e-158]; ENSMUSG00000028134, Ptbp2, polypyrimidine tract binding protein 2, [RH, Score=467, Expect=9e-158]} {Dmel: FBgn0011224, heph, hephaestus, [RH, Score=442, Expect=1e-144]} {Celegans: WBGene00004207, ptb-1, PTB (HnRNP) homolog; Putative RNA-binding protein PTB-1b, [RH, Score=422, Expect=2e-139]} {Smed: dd_Smed_v6_14748_0_1, dd_Smed_v6_14748_0_1, [RH, Score=338, Expect=7e-107]} {RNA1509_47625, RNA1509_7362} {RNA1310_5320, RNA1509_47625} {RNA1509_47625, RNA815_1604} |
83. | MligTC455_35802 | 114 | 2.38 | Mlig455_051876, Mlig455_051902, Mlig455_053140 | Neo: - Age: - |
CACNA2D1 | 2.522 | - | - | 0.792 | 0.749 | - | 0.981 | Mlig455_051876 {REF} {Length: 3144} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=89.1]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=84.7, Expect=2e-16]} {RNA1509_55590} {RNA1310_60852} {RNA815_15380} Mlig455_051902 {REF} {Length: 4662} {Pfam: VWA N-terminal [PF08399.13, score=90.4]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.6]; von Willebrand factor type A domain [PF00092.30, score=38.6]; Cache domain [PF02743.20, score=27.5]; von Willebrand factor type A domain [PF13519.8, score=26.5]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=326, Expect=8e-94]} {Mouse: ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=326, Expect=7e-94]} {Dmel: FBgn0261041, stj, straightjacket, [Score=229, Expect=7e-61]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=141, Expect=9e-34]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=153, Expect=1e-37]} {RNA1509_55590} {RNA1310_7325.1, RNA1509_55590} {RNA1509_55590, RNA815_14878} Mlig455_053140 {REF} {Length: 3265} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.9]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=87.0, Expect=8e-17]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=50.4, Expect=9e-06]} {RNA1509_55590} {RNA1310_7325.1} {RNA815_14878} |
84. | MligTC455_21389 | 173 | 3.6 | Mlig455_012718 | Neo: - Age: - |
SLC9B2 | 2.521 | - | - | - | 0.799 | 0.766 | 0.956 | Mlig455_012718 {REF} {Length: 3209} {Pfam: Sodium/hydrogen exchanger family [PF00999.23, score=114.5]; Sodium/glutamate symporter [PF03616.16, score=18.4]} {Human: ENSG00000164038, SLC9B2, solute carrier family 9 member B2, [Score=320, Expect=3e-100]} {Mouse: ENSMUSG00000050150, Slc9b1, solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1, [RH, Score=303, Expect=5e-94]} {Dmel: FBgn0031865, Nha1, Na[+]/H[+] hydrogen antiporter 1, [Score=257, Expect=4e-75]} {Celegans: WBGene00009618, F41E7.2, [Score=136, Expect=9e-34]} {Smed: dd_Smed_v6_7736_0_2, dd_Smed_v6_7736_0_2, [RH, Score=359, Expect=2e-116]} {RNA1509_19376} {RNA1310_19487} {RNA815_52764} |
85. | MligTC455_10151 | 146 | 3.05 | Mlig455_068692, Mlig455_068719 | Neo: - Age: - |
KREMEN1 | 2.518 | - | - | - | 0.766 | 0.774 | 0.978 | Mlig455_068692 {REF} {Length: 1086} {Pfam: WSC domain [PF01822.21, score=56.5]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=45.4, Expect=7e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=68.9, Expect=2e-14]} {RNA1310_42686} {RNA815_25047} Mlig455_068719 {REF} {Length: 1973} {TRANSSPLICED} {Pfam: WSC domain [PF01822.21, score=55.8]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=45.1, Expect=8e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=67.0, Expect=8e-14]} {RNA1509_56630} {RNA1310_42686} {RNA815_25047} |
86. | MligTC455_53414 | 331 | 6.9 | Mlig455_053442 | Neo: - Age: - Region-specific R2: 4.308 Region-enriched R2: 3.374/0.00040 |
RP1 | 2.515 | - | - | - | 0.768 | 0.757 | 0.990 | Mlig455_053442 {REF} {Length: 1156} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_21828} {RNA1310_33070.1} {RNA815_13802.1} |
87. | MligTC455_21757 | 26 | 0.53 | Mlig455_057867 | Neo: - Age: - |
2.514 | - | - | - | 0.702 | 0.846 | 0.966 | Mlig455_057867 {REF} {Length: 284} {NoTransDecoderORF} {RNA1310_117997} | |
88. | MligTC455_19236 | 1684 | 35.09 | Mlig455_039926 | Neo: - Age: - |
KDM8 | 2.513 | - | - | - | 0.806 | 0.953 | 0.754 | Mlig455_039926 {REF} {Length: 3994} {Pfam: Cupin-like domain [PF13621.8, score=106.1]; EF hand [PF13202.8, score=27.3]; EF hand [PF00036.34, score=23.9]; EF-hand domain pair [PF13499.8, score=21.5]} {Human: ENSG00000155666, KDM8, lysine demethylase 8, [Score=63.2, Expect=4e-10]} {Mouse: ENSMUSG00000030752, Kdm8, lysine (K)-specific demethylase 8, [Score=63.9, Expect=1e-10]} {Dmel: FBgn0035166, CG13902, [Score=68.6, Expect=3e-12]} {Smed: dd_Smed_v6_11273_0_1, dd_Smed_v6_11273_0_1, [Score=224, Expect=1e-68]} {RNA1509_36468, RNA1509_6200} {RNA1310_20380, RNA1509_36468} {RNA1509_36468, RNA815_8139} |
89. | MligTC455_53415 | 319 | 6.64 | Mlig455_053444 | Neo: - Age: Up-Down-Down Region-specific R2: 4.862 Region-enriched R2: 4.179/0.00011 |
RP1 | 2.512 | - | - | - | 0.767 | 0.755 | 0.990 | Mlig455_053444 {REF} {Length: 4944} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.3]; Doublecortin [PF03607.19, score=100.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.5]; Fibroblast growth factor [PF00167.20, score=18.6]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=471, Expect=6e-145]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=453, Expect=3e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.9, Expect=1e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=691, Expect=0.0]} {RNA1509_59703} {RNA1310_2710} {RNA815_17469} |
90. | MligTC455_44713 | 661 | 13.77 | Mlig455_048154 | Neo: - Age: logFC(26M/2M)=0.569 Region-specific R2: 3.883 Region-enriched R2: 3.422/0.00000 |
2.505 | - | 0.773 | - | - | 0.775 | 0.957 | Mlig455_048154 {REF} {Length: 1173} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
91. | MligTC455_31163 | 72 | 1.51 | Mlig455_045625 | Neo: - Age: Up-Down-Down |
2.497 | - | - | - | 0.745 | 0.784 | 0.968 | Mlig455_045625 {REF} {Length: 1957} {RNA1509_21720} {RNA1310_14760, RNA1509_21720} {RNA1509_21720, RNA815_24583} | |
92. | MligTC455_40989 | 801 | 16.68 | Mlig455_016294 | Neo: - Age: logFC(26M/2M)=0.270 |
PKD2 | 2.494 | - | 0.755 | - | - | 0.755 | 0.984 | Mlig455_016294 {REF} {Length: 3179} {Pfam: Polycystin cation channel [PF08016.14, score=486.5]; Ion transport protein [PF00520.33, score=90.3]; EF hand [PF00036.34, score=23.7]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=718, Expect=0.0]; ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [RH, Score=712, Expect=0.0]} {Mouse: ENSMUSG00000037578, Pkd2l1, polycystic kidney disease 2-like 1, [RH, Score=704, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=310, Expect=2e-91]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=370, Expect=7e-116]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=743, Expect=0.0]} {RNA1509_14023, RNA1509_24240} {RNA1310_4836.1, RNA1509_14023, RNA1509_24240} {RNA1509_14023, RNA1509_24240, RNA815_4677} |
93. | MligTC455_43412 | 88 | 1.82 | Mlig455_057184 | Neo: - Age: - |
ANKRD60 | 2.493 | - | - | 0.750 | 0.778 | - | 0.965 | Mlig455_057184 {REF} {Length: 1347} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=42.6]; Ankyrin repeat [PF13606.8, score=33.4]; Ankyrin repeats (many copies) [PF13857.8, score=33.2]; Ankyrin repeat [PF00023.32, score=32.8]; Ankyrin repeats (many copies) [PF13637.8, score=23.4]} {Human: ENSG00000124227, ANKRD60, ankyrin repeat domain 60, [Score=79.3, Expect=5e-16]} {Mouse: ENSMUSG00000027517, Ankrd60, ankyrin repeat domain 60, [Score=70.1, Expect=4e-13]} {Dmel: FBgn0011747, Ank, Ankyrin, [Score=50.8, Expect=1e-06]} {Celegans: WBGene00003196, mel-11, MEL-11, [Score=51.6, Expect=6e-07]} {Smed: dd_Smed_v6_8330_0_1, dd_Smed_v6_8330_0_1, [Score=129, Expect=1e-33]} {RNA1310_18551} {RNA815_10264.1} |
94. | MligTC455_47948 | 100 | 2.07 | Mlig455_005840 | Neo: - Age: - Region-enriched R2: 3.643/0.03527 |
TSPAN16 | 2.493 | - | 0.773 | - | - | 0.752 | 0.968 | Mlig455_005840 {REF} {Length: 2130} {Pfam: Tetraspanin family [PF00335.22, score=86.4]} {Human: ENSG00000130167, TSPAN16, tetraspanin 16, [Score=48.1, Expect=6e-06]} {Mouse: ENSMUSG00000025351, Cd63, CD63 antigen, [Score=50.4, Expect=7e-07]} {Dmel: FBgn0036769, Tsp74F, Tetraspanin 74F, [Score=68.2, Expect=4e-13]} {Smed: dd_Smed_v6_854_1_1, dd_Smed_v6_854_1_1, [Score=119, Expect=5e-32]} {RNA1509_35459} {RNA1310_22253, RNA1509_35459} {RNA1509_35459, RNA815_11065} |
95. | MligTC455_44120 | 125 | 2.61 | Mlig455_041513 | Neo: - Age: Up-Down-Down Region-enriched R2: 7.169/0.00020 |
2.488 | - | - | - | 0.766 | 0.740 | 0.982 | Mlig455_041513 {REF} {Length: 644} {NoTransDecoderORF} {RNA1310_39164} {RNA815_4344} | |
96. | MligTC455_47923 | 9994 | 208.21 | Mlig455_031159, Mlig455_031167 | Neo: - Age: logFC(26M/2M)=-0.423 |
CCDC63 | 2.488 | - | - | - | 0.723 | 0.812 | 0.953 | Mlig455_031159 {REF} {Length: 2325} {TRANSSPLICED} {Pfam: Initiation control protein YabA [PF06156.15, score=22.9]} {Human: ENSG00000173093, CCDC63, coiled-coil domain containing 63, [Score=181, Expect=9e-50]} {Mouse: ENSMUSG00000043036, Ccdc63, coiled-coil domain containing 63, [Score=163, Expect=3e-43]; ENSMUSG00000040189, Ccdc114, coiled-coil domain containing 114, [Score=158, Expect=3e-41]} {Dmel: FBgn0038452, CG14905, [Score=159, Expect=9e-43]} {Celegans: WBGene00001328, epi-1, Laminin-like protein epi-1, [Score=48.5, Expect=1e-05]} {Smed: dd_Smed_v6_4191_0_1, dd_Smed_v6_4191_0_1, [Score=431, Expect=8e-146]} {RNA1509_2578, RNA1509_9264} {RNA1310_10129.1, RNA1509_2578, RNA1509_9264} {RNA1509_2578, RNA1509_9264, RNA815_3341.1} Mlig455_031167 {REF} {Length: 2293} {TRANSSPLICED} {Pfam: Initiation control protein YabA [PF06156.15, score=22.9]} {Human: ENSG00000173093, CCDC63, coiled-coil domain containing 63, [Score=181, Expect=9e-50]} {Mouse: ENSMUSG00000043036, Ccdc63, coiled-coil domain containing 63, [Score=163, Expect=3e-43]; ENSMUSG00000040189, Ccdc114, coiled-coil domain containing 114, [Score=158, Expect=3e-41]} {Dmel: FBgn0038452, CG14905, [Score=159, Expect=9e-43]} {Celegans: WBGene00001328, epi-1, Laminin-like protein epi-1, [Score=48.5, Expect=1e-05]} {Smed: dd_Smed_v6_4191_0_1, dd_Smed_v6_4191_0_1, [Score=431, Expect=8e-146]} {RNA1509_1172, RNA1509_13163, RNA1509_16375, RNA1509_2578} {RNA1310_10129.1, RNA1509_1172, RNA1509_13163, RNA1509_16375} {RNA1509_1172, RNA1509_13163, RNA1509_16375, RNA815_3341.1} |
97. | MligTC455_29408 | 45 | 0.94 | Mlig455_038322 | Neo: - Age: - Region-enriched R2: 8.586/0.00762 |
MB | 2.482 | - | - | - | 0.729 | 0.771 | 0.982 | Mlig455_038322 {REF} {Length: 2059} {Pfam: Globin [PF00042.24, score=57.8]} {Human: ENSG00000198125, MB, myoglobin, [RH, Score=47.8, Expect=5e-07]} {Mouse: ENSMUSG00000018893, Mb, myoglobin, [RH, Score=45.4, Expect=2e-06]} {Celegans: WBGene00008996, glb-14, GLoBin related, [Score=51.6, Expect=4e-08]} {Smed: dd_Smed_v6_15997_0_1, dd_Smed_v6_15997_0_1, [RH, Score=63.5, Expect=1e-12]} {RNA1509_48898} {RNA1310_47695} {RNA815_7096.1} |
98. | MligTC455_24615 | 803 | 16.72 | Mlig455_027166 | Neo: - Age: logFC(26M/2M)=-0.507 |
ECT2 | 2.46 | - | - | - | 0.748 | 0.760 | 0.952 | Mlig455_027166 {REF} {Length: 2510} {Pfam: RhoGEF domain [PF00621.22, score=124.0]; Winged helix-turn helix [PF13592.8, score=20.5]} {Human: ENSG00000114346, ECT2, epithelial cell transforming 2, [Score=80.9, Expect=2e-15]} {Mouse: ENSMUSG00000020640, Itsn2, intersectin 2, [Score=79.7, Expect=5e-15]; ENSMUSG00000027699, Ect2, ect2 oncogene, [Score=77.0, Expect=3e-14]} {Dmel: FBgn0003041, pbl, pebble, [Score=56.6, Expect=5e-08]} {Celegans: WBGene00002297, ect-2, ECT2 (Mammalian Rho GEF) homolog, [Score=69.7, Expect=3e-12]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [Score=50.1, Expect=3e-06]} {RNA1509_21158} {RNA1310_6370} {RNA815_1845} |
99. | MligTC455_44712 | 665 | 13.86 | Mlig455_017186 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.471 Region-specific R2: 4.141 Region-enriched R2: 3.536/0.00000 |
2.456 | - | 0.703 | - | - | 0.788 | 0.965 | Mlig455_017186 {REF} {Length: 1018} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
100. | MligTC455_19325 | 1452 | 30.24 | Mlig455_036471, Mlig455_056256 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.575 Region-enriched R2: 2.298/0.00464 |
2.453 | - | - | - | 0.765 | 0.952 | 0.736 | Mlig455_036471 {REF} {Length: 598} {RNA1509_40294} {RNA1310_65876} {RNA815_35457} Mlig455_056256 {REF} {Length: 599} {RNA1509_40294} {RNA1310_65876, RNA1509_40294} {RNA1509_40294, RNA815_35457} |